Medications/Drugs News

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com: Full Story »

TUESDAY, Nov. 24 (HealthDay News) -- Direct-to-consumer drug ads may contribute to higher Medicaid costs, according to a new study that examined sales of the widely used antiplatelet drug clopidogrel (Plavix). Full Story »

TUESDAY, Nov. 24 (HealthDay News) -- Seniors who take antidepressants, sedatives and other psychotropic medications may be at increased risk for falls, a new review shows. Full Story »

NEW YORK (Reuters Health) - Medicaid pharmacy costs for the blood-thinning drug Plavix jumped at around the same time the drug's maker started advertising it to consumers -- even though the number of people prescribed the drug didn't change, new research shows. Full Story »

WASHINGTON (AFP) - The risks of taking anti-inflammatory drug Vioxx could have been detected nearly four years before the drug was pulled from the market, according to analysis of nearly 30 clinical trials. Full Story »

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com: Full Story »

THURSDAY, Nov. 19 (HealthDay News) -- People's genetic makeup has been shown to affect how they respond to asthma medications, but a new study finds that many people respond well to a particular combination treatment regardless of their genes. Full Story »

(HealthDayNews) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com: Full Story »

LOS ANGELES (Reuters) - Past the security man and his pit bull and through a haze of eye-watering smoke, two youths load up a pipe next to a row of shiny glass jars with two dozen varieties of marijuana bud displayed like candy. Full Story »

WASHINGTON - In a Nov. 17 story about drug interactions between heartburn medications and the blood thinner Plavix, The Associated Press misidentified Johnson & Johnson's Mylanta as part of the H-2 blocker drug family. Mylanta is an antacid. Full Story »

WASHINGTON (Reuters) - Democrats in the U.S. Congress are seeking government investigations into recent price increases of brand-name prescription drugs, as lawmakers finalize an overhaul of the healthcare system. Full Story »

(HealthDayNews) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com: Full Story »

(HealthDayNews) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com: Full Story »

WASHINGTON - Federal health officials said Tuesday a popular variety of heartburn medications can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack and stroke. Full Story »

(HealthDayNews) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com: Full Story »

WASHINGTON (AFP) - With US health care reform at a critical stage, non-generic prescription drug prices have risen sharply in the past year even as other consumer prices generally eased. Full Story »

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com: Full Story »

FRIDAY, Nov. 13 (HealthDay News) -- Seniors enrolled in private, standalone Medicare prescription drugs plans (PDP) could encounter significant changes this open enrollment period, which begins Sunday. Full Story »